Keyword: GlaxoSmithKline (GSK)
News
19.05.2014
- Corruption charges against representatives of UK drugmaker GlaxoSmithKline (GSK) in China are a warning to other foreign firms and could do irreparable damage to the company's...
Strategy & Management
08.05.2014
- In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...
News
07.05.2014
- As expected, Germany's Bayer has emerged as the winner of the race to acquire U.S. Merck's consumer care business. The $14.2 billion deal announced on May 5 is expected to close in...
News
23.04.2014
- Novartis and GlaxoSmithKline have announced an asset swap worth more than $20 billion, with an eye to bolstering their best businesses and exiting weaker ones. The swap, which...
News
15.04.2014
- GlaxoSmithKline (GSK) is facing fresh allegations of corruption, following reported incidents in China and Iraq. Polish authorities have launched a criminal investigation against...
News
11.04.2014
- U.S. biotechnology firm Amgen, the world's largest, is ending its agreement with the U.K. drugmaker GlaxoSmithkline for the marketing of its osteoporosis drug in some regions...
News
10.04.2014
- U.K. drugmaker GlaxoSmithKine (GSK), already facing corruption accusations in China, is now investigating allegations of bribery in Iraq, the company has confirmed. The latest...
News
28.03.2014
- GlaxoSmithKline (GSK), the UK's largest pharmaceutical company, has provisionally withdrawn its marketing authorization application to the European Medicines Agency (EMA) for the...
